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Abstract
Intravenous 0.9% saline has saved countless lives since it was introduced over a century ago. It remains the most
widespread crystalloid in both adult and pediatric practice. However, in recent years, evidence of deleterious effects is
accruing. These include increased mortality, acute kidney injury (AKI), metabolic acidosis, and coagulopathy. The pre-
dominant cause for these sequelae appears to be the excess chloride concentration of 0.9% saline relative to plasma. This
has led to development of balanced isotonic solutions such as PlasmaLyte. This review summarizes current evidence for
adverse effects of chloride-rich intravenous fluid and considers whether 0.9% saline should still be used in 2018 or
abandoned as a historical treatment in favor of balanced crystalloid solutions.
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Introduction
Administration of intravenous fluid directly affects pa-
tients’ extracellular fluid and electrolyte status. While
these effects can be therapeutic, some are unintended,
and have the potential to cause harm. The most commonly
prescribed intravenous crystalloid in pediatric practice is
currently 0.9% saline. There is accruing evidence for ad-
verse effects, most recently in a large randomized trial
demonstrating increased mortality in critically ill adults
[1]. The predominant cause for these sequelae appears to
be the excess chloride concentration of 0.9% saline relative
to plasma. Patients with abnormal kidney function have
reduced capacity to excrete excess chloride, which in-
creases their risk of these complications.
In recent years, balanced intravenous solutions with
physiological chloride concentration have been developed
as isotonic alternatives to 0.9% saline. This review outlines
current evidence for the effects of excess chloride in 0.9%
saline and considers whether its use in clinical practice is
still justified.
Chloride in intravenous fluid
Pediatric practice has changed over the last decade with a
shift away from hypotonic intravenous fluids such as
0.45% saline or 0.2% saline to predominantly 0.9% saline.
The rationale for this change is avoidance of iatrogenic
hyponatremia. Many children in hospital are at increased
risk of hyponatremia due to vasopressin release stimulated
by nausea, pain, gastroenteritis, lung pathology, or the
postoperative state [2, 3]. Hyponatremia is of particular
concern because it predisposes to intracellular fluid shifts
and brain edema which can cause permanent neurological
impairment or even death [4]. Rapid correction of
hyponatremia can also result in neurological complications
such as osmotic demyelination. Systematic reviews have
highlighted the risk of hyponatremia from hypotonic intra-
venous fluid [5–8]. For the majority of children, isotonic
intravenous fluids mitigate these risks [9], although specif-
ic disorders such as diabetes insipidus mandate hypotonic
solutions because isotonic fluids lead to hypernatremia and
cerebral myelinosis [10].
The most commonly prescribed intravenous fluid is cur-
rently 0.9% saline which was developed at the turn of the
twentieth century [11]. While the tonicity and sodium con-
centration of 0.9% saline are within 10% of physiological
levels, its chloride concentration exceeds that of plasma by
approximately 60% (Table 1). In contrast, balanced intrave-
nous fluids have chloride concentrations closely aligned to
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that of plasma. Traditional balanced solutions are
Hartmann’s or Ringer’s lactate [12]. Solutions with even
closer alignment to plasma constituents have subsequently
been developed such as PlasmaLyte (Table 1).
There is accruing evidence for deleterious effects resulting
from excess chloride in patients receiving intravenous 0.9%
saline. Children with impaired kidney function are at particu-
lar risk of these sequelae due to reduced capacity to excrete
excess chloride. The potential mechanisms underlying the ef-
fects of chloride-rich crystalloid will now be discussed.
Effects of chloride
Chloride and mortality
A growing body of evidence highlights an increased mortality
risk in association with administration of chloride-rich intra-
venous fluid.
In a preclinical model of sepsis, fluid resuscitation with
0.9% saline was associated with more metabolic acidosis
and inferior survival than balanced resuscitation fluid [13].
The association of chloride-rich intravenous fluid and mor-
tality is increasingly recognized in critically ill adults. In an
analysis of 53,448 adults with sepsis and acute kidney injury
(AKI), patients who received greater proportions of chloride-
rich fluid experienced increased mortality [14]. A recent clus-
ter-randomized, multiple crossover trial in 15,802 adults on
intensive care found a higher rate of a composite outcome of
death, new renal replacement therapy, or persistent renal dys-
function in patients who received 0.9% saline as opposed to
balanced intravenous crystalloid [1].
In keeping with adult studies, pediatric evidence for a link
between excess chloride andmortality is emerging. In an analysis
of 890 children with septic shock in 29 pediatric intensive care
units in the USA, hyperchloremia was independently associated
with inferior outcomes including mortality and complicated clin-
ical course [15]. This was corroborated in a further single-center
study of 66 children on pediatric intensive care [16].
Notwithstanding the association of chloride-rich intrave-
nous fluid and hyperchloremia with increased mortality,
hypochloremia is also associated with adverse outcomes.
Low serum chloride levels were a strong predictor of mortality
in a 10-year follow-up study of over 9000 adults [17]. The
physiology underlying this association remains to be elucidat-
ed, but the effect appears to be independent of plasma sodium
or potassium concentrations [18, 19].
The mechanism underlying increased mortality in patients
who receive large volumes of chloride-rich crystalloid has not
been definitively established; however hyperchloremic meta-
bolic acidosis is strongly implicated. The physiological basis
for this phenomenon will be outlined in the next section.
Chloride and acid-base balance
Hyperchloremic metabolic acidosis is consistently observed in
both adult and pediatric patients following fluid resuscitation
with 0.9% saline [20, 21]. A Cochrane systematic review of
postoperative intravenous fluid management in adult patients
concluded that chloride-rich fluid, as opposed to balanced fluid,
significantly increases the risk of metabolic acidosis [22].
The cause of metabolic acidosis following an intravenous
chloride load will now be discussed.
Etiology of saline-induced hyperchloremic metabolic acidosis
There are two schools of thought for understanding the mech-
anisms of acute acid-base disturbances. In the traditional
Henderson-Hasselbalch and Siggaard-Anderson line of think-
ing, acute alterations in plasma pH are explained by changes
in partial pressure of carbon dioxide (pCO2) and thereby car-
bonic acid [23]:
The Henderson-Hasselbalch equation
pH ¼ pK þ log HCO3−=pCO2  0:225ð Þ
Using the Henderson-Hasselbalch approach, the link be-
tween excess chloride from 0.9% saline and metabolic acido-
sis is not immediately obvious.
Stewart subsequently published an alternative approach to
understanding acute acid base disturbances [24, 25]. Stewart’s
strong ion theory gives a physiological rationale for excess chlo-
ride driving metabolic acidosis. It refers to principles of electro-
Table 1 Intravenous fluid constituents and properties (with plasma ranges given in first row)
Fluid Osmolality
(mOsm/l)
Na+
(mmol/l)
K+
(mmol/l)
Mg2+
(mmol/l)
Cl−
(mmol/l)
Acetate
(mmol/l)
Gluconate
(mmol/l)
Lactate
(mmol/l)
Plasma 275–295 135–145 3.5–5.3 0.8–1.2 95–108 (Bicarbonate 20–32)
PlasmaLyte 148 295 140 5 1.5 98 27 23
Hartmann’s 278 131 5 111 29
0.9% saline 308 154 154
0.45% saline 4% glucose 376 77 77
0.18% saline 4% glucose 284 31 31
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neutrality (all negatively charged and positively charged ions
must balance) and conservation of mass (the total amount of a
substance remains constant, unless added to, generated, removed
or destroyed). Stewart proposed that acute acid-base balance is
determined by carbon dioxide, weak acids, and the strong ion
difference. Strong ions are almost completely ionized in solution,
and the plasma strong ion difference is defined as
Strong ion difference
¼ Naþ½  þ Kþ½  þ Ca2þ þ Mg2þ  – Cl−½  þ lactate½ ð Þ
Stewart proposed that changes in the strong ion difference
directly alter plasma pH. If a large volume of intravenous 0.9%
saline is administered, this will reduce the plasma strong ion dif-
ference via a higher relative increase in plasma [Cl−] than [Na+].
This reduction in strong ion differencewill increase dissociation of
water to H+ and OH−, thereby driving metabolic acidosis.
To illustrate this phenomenon, the effect of 50 ml/kg intrave-
nous crystalloid (0.9% saline, PlasmaLyte and Hartmann’s) on
the plasma strong ion difference in a 10 kg child who is anuric
postkidney transplant is shown in Fig. 1. A significant change in
strong ion difference results from 0.9% saline which thereby
causes metabolic acidosis. The effect of Hartmann’s solution on
plasma strong ion difference is smaller, and that of PlasmaLyte is
negligible, thereby having no significant effect on the patient’s
acid base balance (Fig. 1).
Alternative explanations for saline-inducedmetabolic acidosis
have also been proposed. They include dilutional acidosis, which
suggests that infusion of buffer-free crystalloid dilutes the bicar-
bonate concentration in extracellular fluid thereby precipitating
acidosis. However, a nonlinear relationship between extracellular
volume expansion and reduction in bicarbonate concentration
does not support this concept [26, 27].
Stewart’s strong ion theory of acute acid-base disturbance
provides a physiologically plausible rationale for the consistent
clinical observation that infusion of chloride-rich fluid results in
metabolic acidosis. Given that metabolic acidosis affects myo-
cardial function, renal and intestinal perfusion, nerve function,
and extracellular potassium buffering, it is likely to play a role in
the increased mortality observed in critically ill patients who
receive large volumes of 0.9% saline.
Chloride and kidney perfusion
Data from preclinical studies and clinical trials suggest a direct
effect of chloride on intra-renal perfusion, vasoconstriction,
and glomerular filtration.
In animal studies, infusion of chloride-rich fluid in dener-
vated kidneys resulted in vasoconstriction and reduction in
glomerular filtration rate [28]. In healthy adult volunteers, renal
artery flow velocity and renal cortical tissue perfusion fell sig-
nificantly from baseline after infusion of 2 litres 0.9% saline,
but not after PlasmaLyte [29]. A chloride-liberal intravenous
fluid strategy was associated with more AKI and renal replace-
ment therapy than a chloride-restrictive strategy in a study of
760 adult patients on intensive care [30]. A recent multiple-
crossover trial comparing 0.9% saline with balanced crystal-
loids in 13,347 noncritically ill adults attending an emergency
department found a higher incidence of major adverse kidney
events following 0.9% saline [31]. These findings were not
corroborated in the SPLIT trial, which compared incidence of
AKI in adults receiving 0.9% saline with PlasmaLyte; howev-
er, the power of this study was limited by small volumes of
fluid infused in patients with moderate severity of disease [32].
In summary, although no pediatric studies have been published
to date, data from pre-clinical models and adult patients strong-
ly implicate chloride-rich intravenous fluid in acutely reducing
kidney blood flow and function.
Chloride and coagulation
There is a consistent theme from preclinical models and clin-
ical studies in adults undergoing major surgery that chloride-
rich resuscitation fluid impairs coagulation.
In an animal model of hemorrhagic shock, resuscitation
with 0.9% saline was associated with hyperchloremic acidosis
and coagulopathy that were not observed with lactated
Ringer’s solution [33]. In adult patients undergoing major
abdominal surgery, chloride-rich intravenous fluid was asso-
ciated with increased blood product requirements [34, 35].
The anticoagulant effect of 0.9% saline has been ascribed to
dilutional coagulopathy related to the significantly larger volume
of saline required for resuscitation relative to balanced fluids
[33]. Further work is needed to definitively delineate the under-
lying pathophysiology; nevertheless, these data constitute a com-
pelling case for balanced intravenous fluid in surgical care.
Chloride and fluid overload
Intravenous fluid can be highly effective in restoring tissue
perfusion in patients with intravascular depletion [36].
Conversely, injudicious use can result in fluid overload. In
children with normal kidney function, fluid overload is un-
common because feedback mechanisms adjusting urine vol-
ume and natriuresis are intact [37]. However, in children with
AKI or chronic kidney disease (CKD), extracellular fluid vol-
ume homeostasis is often perturbed.
Studies in adult patients suggest that chloride-rich crystal-
loid may increase the risk of fluid overload to a greater degree
than balanced solutions. In a study of healthy adult volunteers,
urinary excretion of water and sodium were inferior following
infusion of 2 litres 0.9% saline when compared to Hartmann’s
solution [38]. In the surgical setting, patients receiving 0.9%
saline for volume resuscitation required more blood products
than those who received balanced crystalloids [34, 35]. Blood
products increase the risk of circulatory overload and its
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sequelae [39]. Taken together, these data suggest an increased
risk of fluid overload in patients receiving 0.9% saline as
opposed to balanced solutions.
Fluid overload has serious sequelae. It is associated with
increased mortality in critically ill children and neonates with
AKI [40–43]. It is a key contributor to cardiovascular morbid-
ity and mortality in children with CKD [44]. Avoiding fluid
overload is therefore a key priority, and the potential role of
excess chloride merits further evaluation.
Chloride and blood pressure
While the effect of salt on intravascular volume is well known,
there is accruing evidence to suggest that chloride may influ-
ence blood pressure in its own right [45]. Outside the hospital
setting, the majority of dietary chloride is consumed as NaCl,
so the distinction between sodium and chloride is academic;
however, differentiating the individual contribution of these
ions to blood pressure homeostasis may be important when
selecting intravenous fluid.
Several lines of evidence implicate chloride in systemic
hypertension. Animal and clinical studies found that the hy-
pertensive effect of enteral sodium chloride was not replicated
with sodium citrate or phosphate [46–48]. Further, preclinical
data suggest a specific effect of chloride [49] and other halides
[50] on blood pressure and renal vascular resistance. Recent
understanding of hypertonic electrolyte sequestration in the
skin, and the role of macrophages in regulation of this storage,
has led to the observation that skin chloride accumulation is
associated with systemic hypertension. [51]
0.9% SALINE
50ml/kg
= 500mls
10kg child
Post transplant
[Na+] Plasma[Cl–]
PLASMA-LYTE
HARTMANN’S
154 154
140 140
98
131
111
147
127
140
99
136
106
Plasma
100
[Na+][Cl–]
[Na+][Cl–] Δ SID
20mol/l
1mol/l
10mol/l
Fig. 1 Effects of administering
50 ml/kg of three different intra-
venous fluids to an anuric child
postkidney transplant with he-
matocrit 37.5% and plasma vol-
ume 500 ml (ΔSID change in
strong ion difference)
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With-no-lysine kinases (WNKs) are serine threonine ki-
nases which play a major role in the regulation of sodium
and potassium transport in the distal nephron [52] and in
monogenic hypertension [53]. The importance of intracellular
chloride in WNK signaling was recently elucidated in a
Drosophila model: reduction in intracellular chloride in com-
bination with the regulatory protein Mo25 were found to stim-
ulate WNK activity and transcellular ion flux in the renal
epithelium [54]. This may represent one of the mechanisms
by which chloride affects blood pressure.
While further studies are needed, the importance of chlo-
ride in blood pressure regulation is increasingly recognized.
The case for abandoning 0.9% saline
Given the accruing evidence for deleterious effects of ex-
cess chloride, should physicians abandon chloride-rich
crystalloid, which was developed over a century ago, in
favor of isotonic balanced solutions such as PlasmaLyte?
A number of studies in adult patients and some pediatric
data support this argument.
Traditionally, 0.9% saline was the resuscitation fluid of
choice to manage intravascular depletion. The following data
suggest that this is no longer appropriate: When used as resus-
citation fluid in children on intensive care, balanced fluids
were associated with lower mortality, lower prevalence of
AKI, and lower inotrope requirements in a propensity-
matched analysis of over 3000 children from 43 centers
[55]. Similarly, adult studies demonstrate a consistent link
between chloride-rich resuscitation fluid and subsequent mor-
tality in critically ill patients [14, 56]. Observational data were
recently corroborated in a rigorously conducted randomized
study in over 15,802 adults which confirmed that balanced
crystalloids result in a lower rate of a composite outcome of
death from any cause, new renal-replacement therapy, or per-
sistent renal dysfunction than 0.9% saline [1].
Further studies evidence inferior surgical outcomes in
patients receiving 0.9% saline. In an observational analy-
sis of over 30,000 adult patients undergoing abdominal
surgery, postoperative use of 0.9% saline was associated
with metabolic acidosis, increased mortality, increased in-
fection rates, and increased blood product requirement,
compared to PlasmaLyte [35].
Inferior outcomes are consistently reported in patients at
risk of AKI who receive 0.9% saline. Increased incidence of
AKI was found in a study of 760 adults when a chloride-
liberal intravenous fluid strategy was used, as opposed to a
chloride-restrictive strategy [30]. These findings were not cor-
roborated in the randomized SPLIT trial; however, relatively
small volumes of intravenous fluid were used potentially
blunting a true effect [32]. A meta-analysis found an increase
in AKI and mechanical ventilation time in patients in whom
chloride rich resuscitation fluid was used [57].
Kidney transplantation is a further scenario in which
0.9% saline may impact outcome. Kidney transplant recip-
ients often produce large volumes of urine due to acute
tubular injury and are at increased risk of electrolyte/acid
base disturbances. A Cochrane systematic review of studies
in adult kidney transplant recipients concluded that periop-
erative normal saline was associated with more metabolic
acidosis than balanced solutions [58]. A study comparing
0.9% saline to Ringer’s lactate in adult kidney transplant
recipients was terminated early by the monitoring board
due to significantly more hyperchloremic hyperkalemic
metabolic acidosis in the saline group [59]. The finding of
significantly more hyperkalemia with 0.9% saline than lac-
tated Ringers (containing 4 mmol/l potassium) was corrob-
orated in two further studies in adult kidney transplant re-
cipients [60, 61]. PlasmaLyte (containing 5 mmol/l potassi-
um) has also been shown to reduce the risk of hyperkalemia
relative to potassium-free 0.9% saline in adults with end-
stage kidney disease undergoing transplantation [62, 63].
Although no pediatric data are available, these findings are
noteworthy because pediatric transplant recipients receive
large volumes of intravenous crystalloid to maintain allo-
graft perfusion perioperatively [64].
Although it may seem counterintuitive that potassium con-
taining balanced crystalloids reduce the risk of hyperkalemia
relative to potassium-free saline in patients with impaired kid-
ney function, this is expected when the physiology of potas-
sium homeostasis is considered. Potassium is a predominantly
intracellular ion, and the small proportion of extracellular
(plasma) potassium is regulated by cellular shifts in the short
term. Hyperchloremic acidosis from 0.9% saline impairs cel-
lular buffering of potassium, thereby predisposing to
hyperkalemia. In contrast, the balanced electrolyte composi-
tion, together with plasma bicarbonate resulting from gluco-
nate and acetate metabolism in patients receiving PlasmaLyte,
both serve to maintain cellular potassium buffering. The rela-
tively small quantity of potassium in balanced solutions is
needed to mitigate the risk of hypokalemia. Given the physi-
ology of potassium homeostasis, and the consistent observa-
tion that balanced solutions reduce the risk of hyperkalemia,
concerns about hyperkalemia from potassium in balanced so-
lutions are not justified.
Taken together, there is now overwhelming evidence that
large volumes of 0.9% saline increase the risk of mortality,
metabolic acidosis, and AKI in critically ill adults, and
some data suggesting increased postoperative and trans-
plant complications including hyperkalemia. Pediatric data
are scant so definitive conclusions cannot be drawn; how-
ever, for volume resuscitation and kidney transplant care,
the case for abandoning 0.9% saline in favor of balanced
solutions is compelling.
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The case for keeping 0.9% saline
There are some clinical scenarios in which chloride-rich
crystalloid will remain the intravenous fluid of choice.
For children with hypochloremic metabolic alkalosis and
intravascular volume depletion, the electrolyte composition
of 0.9% saline can aid restoration of physiological electro-
lyte and acid-base balance.
Salt losing tubulopathies such as Bartter syndrome (preva-
lence 1:1,000,000) are disorders of urinary chloride wasting,
with resultant hypochloremic metabolic alkalosis. Children
with these conditions therefore have a high chloride require-
ment. While enteral supplementation with a combination of
sodium and potassium chloride is preferable, intravenous fluid
is required in some situations. For these patients, 0.9% saline
is preferable to a balanced solution. This group is exceptional
in that further addition of chloride in the form of potassium
chloride, resulting in intravenous fluid with chloride concen-
trations up to 194 mmol/l can be indicated.
Cystic fibrosis is a further disorder which predisposes to
excessive chloride loss; excessive sweating can lead to
hypochloremic metabolic alkalosis [65]. While chloride-rich
fluid is not universally indicated in patients with cystic fibrosis,
in the context of intravascular depletion and hypochloremic
alkalosis, 0.9% saline is an appropriate choice of crystalloid.
Children who experience severe persistent vomiting can
develop hypochloremic alkalosis as a result of gastric hy-
drochloric acid loss. Infants with pyloric stenosis are at
particular risk [66]. For patients with hypochloremic alka-
losis due to gastric losses, 0.9% saline with additional po-
tassium chloride can aid normalization of plasma electro-
lyte and acid-base balance.
For children with traumatic brain injury, the hypertonicity of
0.9% saline may mitigate the risk of cerebral edema more effec-
tively than balanced isotonic fluids; however, there is currently
no evidence to support either approach in adults or children [67].
In summary, in clinical conditions which predispose to
hypochloremic alkalosis and intravascular volume depletion,
0.9% saline is preferable to balanced solutions which may not
adequately compensate chloride loss. It can therefore be ar-
gued that 0.9% saline should never be completely abandoned,
because it is the most appropriate crystalloid for some children
as part of an individualized fluid prescription.
Individualized intravenous fluid prescriptions
All children who require intravenous fluid need an individu-
alized prescription that is based on their medical condition and
tailored in response to changes in their fluid, electrolyte, and
acid-base status. This is particularly important in children with
abnormal kidney function, whether AKI or CKD. AKI is com-
mon in critically ill children and associated with increased
mortality [68]. BMaintenance fluid^ can be a dangerous con-
cept for these patients in whom homeostatic mechanisms to
regulate fluid, electrolytes, and acid-base are disturbed.
Special situations should be borne in mind. Children with
diabetes insipidus need hypotonic fluid, and isotonic solutions
are harmful. Those with traumatic brain injury may require
hypertonic solutions. Children with hypochloremic alkalosis
secondary to chloride loss require chloride-rich fluid, often
with added potassium chloride. Such fluid should be avoided
in most patients with AKI or CKD.
While the initial fluid prescription can be based on the
presenting plasma chemistry and acid-base status, careful
monitoring of patients’ fluid status, plasma, and urine elec-
trolytes is paramount in order to tailor the prescription ap-
propriately. BStandard^ intravenous fluid prescriptions are
rarely appropriate; choice of intravenous crystalloid should
be guided by patients’ individual clinical status and adjust-
ed in response to monitoring.
Summary
Evidence is accruing that balanced intravenous fluids mitigate
the deleterious effects of excess chloride in 0.9% saline in
some clinical settings. In adult patients, balanced fluids are
associated with lower mortality, less AKI, and less periopera-
tive complications than 0.9% saline. Concerns about the po-
tassium content of balanced fluids in patients with abnormal
kidney function are not justified, since hyperchloremic acido-
sis from 0.9% saline confers a greater risk of hyperkalemia.
Although pediatric data are scant, balanced isotonic fluids
such as PlasmaLyte are probably better suited to the majority
of children, particularly those with abnormal kidney function
and reduced capacity to excrete excess chloride. Balanced
fluids may have particular advantages when used as isotonic
resuscitation fluid and in kidney transplant recipients.
However, a Bone-size-fits all^ approach to intravenous fluid
must be avoided. Prescriptions must be tailored to each indi-
vidual child’s needs considering their underlyingmedical con-
dition, plasma chemistry, and fluid status. Many hospitalized
children do not Bneed^ intravenous fluid at all; the enteral
route is safer and should always be the default.
Multiple-choice questions (answers are provided following
the reference list)
1. Hyperchloremic metabolic acidosis can be explained by:
a. An increase in the plasma strong ion difference
b. A reduction in the plasma strong ion difference
c. An increase in the plasma partial pressure of CO2
d. Inhibition of dissociation of water to ionized
constituents
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2. 0.9% saline has the following properties, relative to
plasma:
3. PlasmaLyte contains the following constituents:
a. Na, Cl, lactate
b. Na, Cl, K, Ca, acetate, gluconate
c. Na, Cl, K, Mg, acetate, gluconate
d. Na, Cl, K, Ca, Mg, acetate
4. Deleterious effects of 0.9% resuscitation fluid in adults
include:
a. Increased mortality
b. Acidosis
c. Increased blood product requirement
d. All of the above
5. Addition of 20 mmol potassium chloride to 500 ml 0.9%
saline results in a chloride concentration of:
a. 154 mmol/l
b. 164 mmol/l
c. 174 mmol/l
d. 194 mmol/l
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